Acadia Healthcare posted revenue of $865.8 million in the second quarter, little changed from a year earlier.
Net income attributable to shareholders fell 64% to $10.9 million, with GAAP diluted EPS down 64% to $0.12.
Non-GAAP adjusted EBITDA dropped 26% to $149.2 million, reflecting a $28.6 million PLGL reserve adjustment and a $26.1 million Florida supplemental benefit.
Cash flow, capacity additions and guidance
Operating cash flow rose to $162.1 million; capital spending fell to $38.6 million.
Acadia added 240 licensed beds from newly constructed facilities.
Debbie Osteen cited new JV openings and strong free cash flow, while raising 2026 guidance for non-GAAP adjusted EBITDA to $590 million-$615 million.
ACHC•
